Results 11 to 20 of about 219,523 (189)

Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations

open access: yesDrugs in Context, 2014
Tardive dyskinesia (TD) is a disfiguring side-effect of antipsychotic medications that is potentially irreversible in affected patients. Newer atypical antipsychotics are felt by many to have a lower risk of TD.
Jungjin Kim   +2 more
doaj   +2 more sources

Constrictive Pericarditis Associated with Atypical Antipsychotics

open access: yesCase Reports in Cardiology, 2012
We report the successful surgical intervention in a case of constrictive pericarditis after long-term use of atypical antipsychotics. Pericarditis developed in our patient with a longstanding history of schizophrenia treated with atypical antipsychotics.
Kuan-chin Jean Chen   +3 more
doaj   +2 more sources

Clozapine-Induced Phototoxicity: An Unusual Side Effect of Atypical Antipsychotics

open access: yesCase Reports in Dermatological Medicine, 2018
Introduction. Clozapine is a second-generation antipsychotic used for treatment-refractory schizophrenia. Photosensitivity is a major concern when prescribing typical antipsychotics, while atypical antipsychotics are thought to be less photosensitive ...
S. Al-Aojan, A. Al-Khalifah
doaj   +2 more sources

ATYPICAL ANTIPSYCHOTICS USE IN CHILDREN AND ADOLESCENTS [PDF]

open access: yesZdravniški Vestnik, 2002
Background. Classical antipsychotics – neuroleptics are one of the most frequently prescribed psychotropic drugs in child psychiatry. Atypical antipsychotics are used for the same indications – psychotic (schizophrenia) as well as unpsychotic disorders ...
Nataša Potočnik-Dajčman   +1 more
doaj   +1 more source

Torsadogenic risk of antipsychotics : combining adverse event reports with drug utilization data across Europe [PDF]

open access: yes, 2013
Antipsychotics (APs) have been associated with risk of torsade de Pointes (TdP). This has important public health implications. Therefore, (a) we exploited the public FDA Adverse Event Reporting System (FAERS) to characterize their torsadogenic profile; (
Kalaba, Marija   +10 more
core   +3 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database. [PDF]

open access: yes, 2013
Objective. Assess risk of cardiac events and mortality among users of olanzapine and other antipsychotics relative to nonusers. Methods. The General Practice Research Database was used to identify cohorts of antipsychotic users and nonusers with ...
Van Staa, Tjeerd; id_orcid   +8 more
core   +1 more source

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis [PDF]

open access: yes, 2000
Objective To develop an evidence base for recommendations on the use of atypical antipsychotics for patients with schizophrenia.Design Systematic overview and meta-regression analyses of randomised controlled trials, as a basis for formal development of ...
Freemantle, Nick   +9 more
core   +1 more source

Weight Gain in Children and Adolescents Taking Atypical Antipsychotics [PDF]

open access: yes, 2004
Atypical antipsychotic use in children is increasing faster than any other psychotropic used with children. Children and adolescents are being prescribed atypicals to treat a great range of symptoms.
McClure, Heather
core   +3 more sources

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials

open access: yesBMC Psychiatry, 2007
Background Atypical antipsychotics are increasingly used for treatment of mental illnesses like schizophrenia and bipolar disorder, and considered to have fewer extrapyramidal effects than older antipsychotics.
Moore R Andrew, Derry Sheena
doaj   +1 more source

Home - About - Disclaimer - Privacy